Novel Taurinamide-Based Compounds as Carbonic Anhydrase Inhibitors.

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Enzyme Inhibition

Background:

• Human carbonic anhydrases (hCAs) are crucial enzymes with significant biomedical relevance.
• Targeting specific hCA isoforms is key for developing effective therapeutics.
• Taurinamide derivatives represent a potential class of enzyme inhibitors.

Purpose of the Study:

• To investigate the inhibitory effects of novel taurinamide-based amides on various human carbonic anhydrase isoforms.
• To identify potent and selective inhibitors for hCA isoforms relevant to disease.
• To elucidate the structure-activity relationships of these compounds.

Main Methods:

• Synthesis and characterization of 19 taurinamide-based amides.
• In vitro inhibition assays against hCA isoforms I, II, VA, VII, IX, and XII.
• Determination of inhibition constants (K_I).
• X-ray crystallography to determine enzyme-inhibitor complex structures.

Main Results:

• Most derivatives exhibited affinity and selectivity for hCA I.
• Compounds 1, 2, 4, 8, and 9 were identified as potent nanomolar inhibitors of hCA I and hCA IX.
• K_I values ranged from 0.65-0.83 µM for hCA I and 0.59-0.96 µM for hCA IX.
• X-ray structures revealed detailed binding modes and molecular determinants.

Conclusions:

• Taurinamide-based amides are effective inhibitors of human carbonic anhydrase isoforms.
• Substitution patterns significantly influence inhibitor affinity and selectivity.
• These findings provide a foundation for the rational design of new hCA-targeted drugs.